WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION
PendingCombined Mark
•
Never miss important updates for WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Ownership
CP
Address
200 CROSSING BLVD., 211 Mt. Airy Road
Bridgewater, NJ 08807
Critical Dates
First Use Date
Jan 5, 2010
Filing Date
Oct 27, 2009
Registration Date
Aug 30, 2011
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for the reduction of elevated cholesterol in patients having primary hypercholesterolemia; pharmaceutical preparations for the treatment of diabetes
Mark Elements
Text Mark
WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description
The mark consists of two arrows which appear to left of the word "WELCHOL". The larger, outer arrow appears in the colors blue and green and the arrow connects to the right-hand portion of the letter "W" in the word "WELCHOL", which is in the color green. The smaller, inner arrow appears in the colors yellow and green and connects to the left-hand portion of the letter "W" in "WELCHOL". Both arrows converge to the left of the word "WELCHOL", sharing the same green arrowhead. The letter "W" in "WELCHOL" is capitalized. The words "COLESEVELAM HCI", enclosed in parentheses, appear in small, black letters, immediately beneath the "LCHOL" portion of the word "WELCHOL". The parenthesis are also black. The words "FOR ORAL SUSPENSION" appear immediately beneath "(COLESEVELAM HCI)" in the color green.
Color Details
The color(s) blue, green, yellow and black is/are claimed as a feature of the mark.
Design Search Codes
24.15.01
Arrows forming a circle or an arc of a circle24.15.10
Arrows, more than one24.15.25
Other arrowsRelated Registrations
2493507
3122563
3473865
Trademark Timeline
Filing Date
First Use
Publication Date
Registration Date
Trademark Assignment
Assigned to COSETTE PHARMACEUTICALS, INC.
USPTO Records
No documents found for this trademark.